USCAP 114th Annual Meeting

Stop by Booth #234

We will once again be exhibiting at the USCAP 114th Annual Meeting, and there is so much we are excited to share with you this year.

We have developed a suite of products designed to work for every patient, even as cancers evolve. Our test menu is regularly updated to provide solutions that align to the latest evidence and guidelines.

NeoGenomics is THE premier provider of precision oncology tests.

Request a Meeting

Precision testing options for pathologists

We are the market leader in heme oncology solutions - our hematological solutions support the care continuum with profiles that detect genomic alterations relevant to diagnostic evaluation, prognosis, risk assessment and therapy selection.

  • NEO | Compass
  • NEO | Compass Select
  • NEO | Comprehensive® - Heme Cancers

Our lung solutions support the care continuum with profiles that detect genomic alterations relevant to diagnosis, prognosis, therapy selection and clinical trial options.

  • NEO | Comprehensive® - Solid Tumor
  • NEO | Early-stage NSCLC Panel
  • NEO | DNA & RNA - Lung
  • NEO | InVisionFirst® - Lung

© NeoGenomics Laboratories
9490 NeoGenomics Way
Fort Myers, FL 33912
Privacy Policy